Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities

Author:

Venkatakrishnan K1,Friberg LE2,Ouellet D3,Mettetal JT4,Stein A5,Trocóniz IF6,Bruno R7,Mehrotra N8,Gobburu J9,Mould DR10

Affiliation:

1. Clinical Pharmacology; Takeda Pharmaceuticals International Co.; Cambridge Massachusetts USA

2. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

3. Clinical Pharmacology; Modeling & Simulation, GlaxoSmithKline; Research Triangle Park North Carolina USA

4. Drug Safety and Metabolism, AstraZeneca R&D; Waltham Massachusetts USA

5. Novartis Institutes for Biochemical Research; Cambridge Massachusetts USA

6. Department of Pharmacy and Pharmaceutical Technology; University of Navarra; Pamplona Spain

7. Pharsight Consulting Services, Pharsight, A Certara Company; Marseille France

8. Division of Pharmacometrics, Office of Clinical Pharmacology; U.S. Food and Drug Administration; Silver Spring Maryland USA

9. Center for Translational Medicine; School of Pharmacy, University of Maryland; Baltimore Maryland USA

10. Projections Research Inc; Phoenixville Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3